The Role of immunohistochemical Expression of monoclonal VE1 antibody in detecting the BRAF gene mutation in patients with colorectal carcinoma.
Keywords:Colorectal carcinoma, BRAF gene, immunohistochemistry method.
Purposes of study : to evaluate clinical parameters and histopathological features of Colorectal carcinoma (CRC) and its association with BRAF mutation as immunohistochemical markers in Babylon province. Methods: This research is prospective study. The total patients are 42 Manual IHC staining procedure were done. Staining intensity were scored as: 0 ( negative ), 1 (weak diffuse staining in comparing to background staining ), 2 (moderate diffuse staining), and 3 (strong diffuse staining) . IHC scoring was regarding as positive when there was diffuse, homogenous and more than 80% of cytoplasmic staining area of cancer cells. Negative cases when there were absent staining or nuclear staining or weak isolated staining cells. Score 0 and 1 were consider negative and score 2 and 3 were positive. Results: Positive IHC staining of BRAF mutation was presenting more in older age group (65 ±15.23years) , male gender (60%) and left sided colon (60%) but there were insignificant association of these above parameters. Grade 2 and grade 3 of CRC was the highest frequency of positive BRAF cases (40%). Positive IHC staining for BRAF mutation expression is more frequency in T3, N1-2, and M0 stage, and stage III that shows 60%, 80%, 100%, 80% respectively. There were no significant association between BRAF IHC with TMN staging and grading systems. Conclusion: the current study found to be predominant in older age ( > 65 years old) , high grade (G2-3) and high stage (III). Parameters of high grade & stage associated with poor prognosis & high mortality outcome. BRAF gene IHC expression could be consider an independent bad prognostic factor for patients with CRC .
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Re use and mixing of content policy- We follow Creative Commons Licence Policy. We follow CC BY. Please refer below for all details
This license lets others distribute, remix, adapt, and build upon our work, even commercially, as long as they credit us for the original creation.
- The journal allows readers to read, download, copy, distribute, print, search, or link to the full texts of its articles and allow readers to use them for any other lawful purpose.
- The journal allows the author(s) to hold the copyright without restrictions.
- The journal allows the author(s) to retain publishing rights without restrictions